Portfolio company
GeneCentric
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops gene expression-based liquid biopsy platforms and biomarkers to help pharmaceutical and diagnostic firms identify cancer treatment responders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
LiquidCell Dx
This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.
Foresight Diagnostics
This company develops liquid biopsy tests to detect minimal residual disease in cancer patients for biopharmaceutical companies and healthcare providers.
geninus
This company provides genomic analysis solutions and single-cell diagnostic platforms for pharmaceutical firms, healthcare providers and clinical researchers to enable precision medicine.
Avant Genomics
The company develops an automated platform for liquid biopsy sample preparation to assist clinical laboratories in cancer detection and monitoring.
Infiniplex
This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.
Cofactor Genomics
This company develops RNA-based diagnostic tests and predictive immune modelling to help healthcare providers and pharmaceutical researchers identify patient responses to immunotherapy.
Enumera Molecular
The company develops genomic analysis platforms and workflows for clinical laboratories to perform rapid and cost-effective liquid biopsy and diagnostic testing.
Fyr Bio
This company develops liquid biopsy diagnostic tools and biomarkers using extracellular vesicle enrichment technology for healthcare providers and pharmaceutical researchers.
